William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
William Blair says buy the dip on Jones Lang LaSalle (JLL)
-
Allworth Financial Announces Expansion of Strategic Investor Group
-
William Blair Downgrades Expand Energy (EXE) to Market Perform
-
William Blair Reiterates Outperform Rating on Alphabet (GOOGL)
-
Form 485BPOS WILLIAM BLAIR FUNDS
-
LifeStance to Present at Upcoming Investor Conferences
-
Guardant Health to Participate in Upcoming Investor Conferences
-
Viking Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
-
William Blair on SoFi Technologies (SOFI): 'Buy on weakness'
-
SoFi's unchanged 2026 forecast eclipses record results, shares fall
-
William Blair Starts Akoustis Technologies (AKTS) at Outperform
-
Visa shares climb as profit beat, raised forecast ease Middle East jitters
-
William Blair Downgrades Tenable (TENB) to Market Perform
-
William Blair Downgrades Rapid7 (RPD) to Market Perform
-
William Blair Downgrades Qualys (QLYS) to Market Perform
-
William Blair: 'we continue to view BridgeBio as a core smidcap biotech holding'
-
Broadtree Partners Announces $240 Million Multi-Asset Continuation Fund
-
Acron Technologies Acquires Sightline Intelligence, Expanding Its Advanced Defense Capabilities
-
Honeywell names 11-member board for aerospace spinoff
-
Honeywell Announces Board of Directors for Honeywell Aerospace
-
William Blair Starts Cencora Inc (COR) at Market Perform
-
William Blair Starts McKesson (MCK) at Outperform
-
William Blair Starts Cardinal Health (CAH) at Outperform
-
Compass Therapeutics stock plunges on trial data concerns, William Blair comments
-
William Blair on Compass Therapeutics (CMPX) 75% Drop: 'This will raise questions on the approvability of this dataset'
-
HawkEye 360 launches IPO roadshow seeking to raise up to $416 million
-
Viant to Participate in Upcoming Investor Conferences
-
HawkEye 360 Announces Launch of Initial Public Offering Roadshow
-
Suja Life begins IPO roadshow with shares priced at $21-$24
-
Suja Life (SUJA) files for 8.89M share IPO at $21-$24/sh
-
Suja Life Announces Launch of Initial Public Offering
-
Musk sounds cautious tone on robotaxis amid slower-than-expected rollout
-
William Blair on Pool Corp (POOL): 'We expect shares to have a muted reaction'
-
Tesla stock reverses course as capex hike offsets Q1 beat
-
AmEx beats profit estimates as spending growth hits three-year high
-
William Blair on GE Vernova (GEV): 'would use pullbacks or macro volatility to add to positions'
-
ServiceNow Reports First Quarter 2026 Financial Results
-
Axon to Release First Quarter 2026 Earnings on May 6, 2026
-
William Blair on Kyverna Therapeutics Inc (KYTX): AAN updates 'extremely positive,' data supports BLA
-
William Blair on Waste and Recycling Names: 'Good Buys on Discounted Relative Valuation'
-
Healthcare Services Group Reports First Quarter Results
-
William Blair Downgrades Driven Brands (DRVN) to Market Perform
-
William Blair Comments on CarMax (KMX): 'we remain comfortable with our projection for flattish used unit comps in the May quarter'
-
William Blair Comments on Carvana (CVNA): 'we now project used units sold of 184,600 in the first quarter'
-
William Blair expects 'strong quarter' from Carvana (CVNA), sees top and bottom line beats
-
American Public Education, Inc. Schedules First Quarter 2026 Earnings Call and Announces Upcoming Conference Participation
-
William Blair stays Outperform on Eupraxia Pharmaceuticals (EPRX) as data shows 'robust response'
-
William Blair Upgrades kforce.com (KFRC) to Outperform
-
William Blair Upgrades Robert Half (RHI) to Outperform
-
Kailera raises $718.8 million in initial public offering

